Skip to main content

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
Cancel
×
×
Home
  • Home
Article
  • Cited by 27
  • Cited by
    Crossref Citations
    Crossref logo
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.
    Hsieh, Men-Ting Lin, Pao-Yen Tsai, Chia-Jen Chang, Chiung-Chih and Lee, Yu 2017. Tardive akathisia related to the anti-hypertensive agent Sevikar-a case report. BMC Pharmacology and Toxicology, Vol. 18, Issue. 1,
    Praharaj, Samir Kumar Kongasseri, Sreejayan Behere, Rishikesh V. and Sharma, Podila Satya Venkata Narasimha 2015. Mirtazapine for antipsychotic-induced acute akathisia: a systematic review and meta-analysis of randomized placebo-controlled trials. Therapeutic Advances in Psychopharmacology, Vol. 5, Issue. 5, p. 307.
    Jethwa, Ketan Dipak 2015. Pharmacological management of antipsychotic-induced akathisia: an update and treatment algorithm. BJPsych Advances, Vol. 21, Issue. 5, p. 342.
    Poyurovsky, Michael and Weizman, Abraham 2015. Treatment of Antipsychotic-Related Akathisia Revisited. Journal of Clinical Psychopharmacology, Vol. 35, Issue. 6, p. 711.
    Poyurovsky, Michael Bergman, Josef Pashinian, Artashez and Weizman, Abraham 2014. Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia. International Clinical Psychopharmacology, Vol. 29, Issue. 5, p. 296.
    Sethuram, Karthik and Gedzior, Joanna 2014. Akathisia: Case Presentation and Review of Newer Treatment Agents. Psychiatric Annals, Vol. 44, Issue. 8, p. 391.
    Chen, Mu-Hong and Liou, Ying-Jay 2013. Aripiprazole-Associated Acute Dystonia, Akathisia, and Parkinsonism in a Patient With Bipolar I Disorder. Journal of Clinical Psychopharmacology, Vol. 33, Issue. 2, p. 269.
    Ribosa-Nogué, Roser Pagonabarraga, Javier and Kulisevsky, Jaime 2012. Efficacy of trazodone in antipsychotic-induced akathisia resistant to conventional treatment. Parkinsonism & Related Disorders, Vol. 18, Issue. 7, p. 902.
    Fahn, Stanley Jankovic, Joseph and Hallett, Mark 2011. Principles and Practice of Movement Disorders. p. 415.
    Advokat, Claire 2010. A Brief Overview of Iatrogenic Akathisia. Clinical Schizophrenia & Related Psychoses, Vol. 3, Issue. 4, p. 226.
    Stryjer, Rafael Rosenzcwaig, Silvio Bar, Faina Ulman, Ann Marie Weizman, Abraham and Spivak, Baruch 2010. Trazodone for the Treatment of Neuroleptic-Induced Acute Akathisia. Clinical Neuropharmacology, Vol. 33, Issue. 5, p. 219.
    Poyurovsky, Michael 2010. Acute antipsychotic-induced akathisia revisited. British Journal of Psychiatry, Vol. 196, Issue. 02, p. 89.
    Hieber, Robin Dellenbaugh, Timothy and Nelson, Leigh Anne 2008. Role of Mirtazapine in the Treatment of Antipsychotic-Induced Akathisia. Annals of Pharmacotherapy, Vol. 42, Issue. 6, p. 841.
    Goudie, Andrew J. Cooper, Gillian D. Cole, Jon C. and Sumnall, Harry R. 2007. Cyproheptadine resembles clozapine in vivo following both acute and chronic administration in rats. Journal of Psychopharmacology, Vol. 21, Issue. 2, p. 179.
    Braude, Darren and Boling, Sandy 2006. Case report of unrecognized akathisia resulting in an emergency landing and RSI during air medical transport. Air Medical Journal, Vol. 25, Issue. 2, p. 85.
    Poyurovsky, Michael Pashinian, Artashes Weizman, Ronit Fuchs, Camil and Weizman, Abraham 2006. Low-Dose Mirtazapine: A New Option in the Treatment of Antipsychotic-Induced Akathisia. A Randomized, Double-Blind, Placebo- and Propranolol-Controlled Trial. Biological Psychiatry, Vol. 59, Issue. 11, p. 1071.
    2006. Atlas of Psychiatric Pharmacotherapy, Second Edition. p. 147.
    Ranjan, Sanjeev Chandra, Prabha S Chaturvedi, Santosh K Prabhu, Santosh C and Gupta, Arun 2006. Atypical Antipsychotic–Induced Akathisia with Depression: Therapeutic Role of Mirtazapine. Annals of Pharmacotherapy, Vol. 40, Issue. 4, p. 771.
    Miodownik, Chanoch Lerner, Vladimir Statsenko, Nikolay Dwolatzky, Tzvi Nemets, Boris Berzak, Elina and Bergman, Joseph 2006. Vitamin B6 Versus Mianserin and Placebo in Acute Neuroleptic-induced Akathisia. Clinical Neuropharmacology, Vol. 29, Issue. 2, p. 68.
    2005. The Maudsley 2005-2006 Prescribing Guidelines. p. 7.
    Download full list
    ×
  • Access

Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: A new approach to an old problem

  • Michael Poyurovsky (a1) and Abraham Weizman (a1)
  • View HTML
      • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: A new approach to an old problem
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: A new approach to an old problem
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: A new approach to an old problem
      Available formats
      ×
Abstract
Copyright
COPYRIGHT: © Royal College of Psychiatrists, 2001 
Corresponding author
A. Weizman, Research Unit, Geha Psychiatric Hospital, PO Box 102, PetahTiqva 49100, Israel. Tel: +972 3 9258290; Fax: +972 3 9241041; e-mail: weizmana@post.tau.ac.il
References
Hide All
Adler, L. A., Angrist, B., Retter, S., et al (1989) Neuroleptic-induced akathisia: a review. Psychopharmacology, 97, 1–11.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.
Barnes, T. R. E. (1989) A rating scale for drug-induced akathisia. British Journal of Psychiatry, 154, 672–676.
Barnes, T. R. E. & McPhillips, M. A. (1999) Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics. British Journal of Psychiatry, 174 (suppl. 38), 34–43.
D'Mello, D. A., McNeil, J. A. & Harris, W. (1989) Buspirone suppression of neuroleptic-induced akathisia: multiple case reports (letter). Journal of Clinical Psychopharmacology, 9, 151–152.
Fischel, T., Hermesh, H., Alzenberg, D., et al (2001) Cyproheptadine vs. propranolol for the treatment of acute neuroleptic-induced akathisia: A comparative double-blind study. Journal of Clinical Psychopharmacology, in press.
Fleischhacker, W. W., Roth, S. D. & Kane, J. M. (1990) The pharmacologic treatment of neuroleptic-induced akathisia. Journal of Clinical Psychopharmacology, 10, 12–21.
Kapur, S. & Remington, G. (1996) Serotonin – dopamine interaction and its relevance to schizophrenia. American Journal of Psychiatry, 153, 466–476.
Lane, R. M. (1998) SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. Journal of Psychopharmacology, 12, 192–214.
Leysen, J. E., Gommeren, W. & Shotte, A. (1996) Serotonin receptor subtypes: possible roles and applications in antipsychotic drug action. In Serotonin in Antipsychotic Treatment. Mechanisms and Clinical Practice (eds Kane, J. M., Moller, H.-J. & Awouters, F.), pp. 51–75. New York: Marcel Dekker.
Meltzer, H. Y. (1999) The role of serotonin in antipsychotic drug action. Neuropsychopharmacology, 21 (suppl. 2), 106S–115S.
Miller, G. H., Fleischhacker, W. W., Ehrman, H., et al (1990) Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist ritanserin. Psychopharmacology Bulletin, 26, 373–376.
Miller, C. H., Hummer, M., Pycha, R., et al (1992) The effect of ritanserin on treatment-resistant neuroleptic-induced akathisia: case reports. Progress in Neuropsychopharmacology and Biological Psychiatry, 16, 247–251.
Poyurovsky, M. & Weizman, A. (1997) Serotonergic agents in the treatment of acute neuroleptic-induced akathisia: open-label study of buspirone and mianserin. International Clinical Psychopharmacology, 12, 263–268.
Poyurovsky, M. & Weizman, A. (1999) Lack of efficacy of the 5-HT3 receptor antagonist granisetron in the treatment of acute neuroleptic-induced akathisia. International Clinical Psychopharmacology, 14, 357–360.
Poyurovsky, M. & Weizman, A. (2001) Low dose mirtazapine ameliorates acute neuroleptic-induced akathisia (letter). American Journal of Psychiatry, in press.
Poyurovsky, M., Fuchs, C. & Weizman, A. (1998) Low-dose mianserin in the treatment of acute neuroleptic-induced akathisia. Journal of Clinical Psychopharmacology, 18, 253–254.
Poyurovsky, M., Shardorodsky, M., Fuchs, C., et al (1999) Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin. Double-blind, placebo-controlled study. British Journal of Psychiatry, 174, 238–242.
Richelson, E. (1996) Preclinical pharmacology of neuroleptics; focus on new generation compounds. Journal of Clinical Psychiatry, 57 (suppl. 11), 4–10.
Seeman, P. & Tallerico, T. (1998) Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors yet occupy high levels of these receptors. Molecular Psychiatry, 3, 123–134.
Weiss, D., Aizenberg, D., Hermesh, H., et al (1995) Cyproheptadine treatment in neuroleptic-induced akathisia. British Journal of Psychiatry, 167, 483–486.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *

CAPTCHA *

Skip to the audio challenge
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

  • Cited by 27
  • Cited by
    Crossref Citations
    Crossref logo
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.
    Hsieh, Men-Ting Lin, Pao-Yen Tsai, Chia-Jen Chang, Chiung-Chih and Lee, Yu 2017. Tardive akathisia related to the anti-hypertensive agent Sevikar-a case report. BMC Pharmacology and Toxicology, Vol. 18, Issue. 1,
    Praharaj, Samir Kumar Kongasseri, Sreejayan Behere, Rishikesh V. and Sharma, Podila Satya Venkata Narasimha 2015. Mirtazapine for antipsychotic-induced acute akathisia: a systematic review and meta-analysis of randomized placebo-controlled trials. Therapeutic Advances in Psychopharmacology, Vol. 5, Issue. 5, p. 307.
    Jethwa, Ketan Dipak 2015. Pharmacological management of antipsychotic-induced akathisia: an update and treatment algorithm. BJPsych Advances, Vol. 21, Issue. 5, p. 342.
    Poyurovsky, Michael and Weizman, Abraham 2015. Treatment of Antipsychotic-Related Akathisia Revisited. Journal of Clinical Psychopharmacology, Vol. 35, Issue. 6, p. 711.
    Poyurovsky, Michael Bergman, Josef Pashinian, Artashez and Weizman, Abraham 2014. Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia. International Clinical Psychopharmacology, Vol. 29, Issue. 5, p. 296.
    Sethuram, Karthik and Gedzior, Joanna 2014. Akathisia: Case Presentation and Review of Newer Treatment Agents. Psychiatric Annals, Vol. 44, Issue. 8, p. 391.
    Chen, Mu-Hong and Liou, Ying-Jay 2013. Aripiprazole-Associated Acute Dystonia, Akathisia, and Parkinsonism in a Patient With Bipolar I Disorder. Journal of Clinical Psychopharmacology, Vol. 33, Issue. 2, p. 269.
    Ribosa-Nogué, Roser Pagonabarraga, Javier and Kulisevsky, Jaime 2012. Efficacy of trazodone in antipsychotic-induced akathisia resistant to conventional treatment. Parkinsonism & Related Disorders, Vol. 18, Issue. 7, p. 902.
    Fahn, Stanley Jankovic, Joseph and Hallett, Mark 2011. Principles and Practice of Movement Disorders. p. 415.
    Advokat, Claire 2010. A Brief Overview of Iatrogenic Akathisia. Clinical Schizophrenia & Related Psychoses, Vol. 3, Issue. 4, p. 226.
    Stryjer, Rafael Rosenzcwaig, Silvio Bar, Faina Ulman, Ann Marie Weizman, Abraham and Spivak, Baruch 2010. Trazodone for the Treatment of Neuroleptic-Induced Acute Akathisia. Clinical Neuropharmacology, Vol. 33, Issue. 5, p. 219.
    Poyurovsky, Michael 2010. Acute antipsychotic-induced akathisia revisited. British Journal of Psychiatry, Vol. 196, Issue. 02, p. 89.
    Hieber, Robin Dellenbaugh, Timothy and Nelson, Leigh Anne 2008. Role of Mirtazapine in the Treatment of Antipsychotic-Induced Akathisia. Annals of Pharmacotherapy, Vol. 42, Issue. 6, p. 841.
    Goudie, Andrew J. Cooper, Gillian D. Cole, Jon C. and Sumnall, Harry R. 2007. Cyproheptadine resembles clozapine in vivo following both acute and chronic administration in rats. Journal of Psychopharmacology, Vol. 21, Issue. 2, p. 179.
    Braude, Darren and Boling, Sandy 2006. Case report of unrecognized akathisia resulting in an emergency landing and RSI during air medical transport. Air Medical Journal, Vol. 25, Issue. 2, p. 85.
    Poyurovsky, Michael Pashinian, Artashes Weizman, Ronit Fuchs, Camil and Weizman, Abraham 2006. Low-Dose Mirtazapine: A New Option in the Treatment of Antipsychotic-Induced Akathisia. A Randomized, Double-Blind, Placebo- and Propranolol-Controlled Trial. Biological Psychiatry, Vol. 59, Issue. 11, p. 1071.
    2006. Atlas of Psychiatric Pharmacotherapy, Second Edition. p. 147.
    Ranjan, Sanjeev Chandra, Prabha S Chaturvedi, Santosh K Prabhu, Santosh C and Gupta, Arun 2006. Atypical Antipsychotic–Induced Akathisia with Depression: Therapeutic Role of Mirtazapine. Annals of Pharmacotherapy, Vol. 40, Issue. 4, p. 771.
    Miodownik, Chanoch Lerner, Vladimir Statsenko, Nikolay Dwolatzky, Tzvi Nemets, Boris Berzak, Elina and Bergman, Joseph 2006. Vitamin B6 Versus Mianserin and Placebo in Acute Neuroleptic-induced Akathisia. Clinical Neuropharmacology, Vol. 29, Issue. 2, p. 68.
    2005. The Maudsley 2005-2006 Prescribing Guidelines. p. 7.
    Download full list
    ×
  • Access

Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: A new approach to an old problem

  • Michael Poyurovsky (a1) and Abraham Weizman (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *

Cancel
Confirm
×